QUADRUPLE THREAT: A phase II trial of RRx-001 followed by etoposide-platinum re-challenge in previously treated small cell lung cancer. Padda, S., Brzezniak, C. E., Waqar, S., Wakelee, H. A., Ma, P. C., Rose, M. G., Reid, T., Spira, A. I., Wong, E., Zeman, K., Oronsky, B., Abrouk, N. D., Morgensztern, D. AMER SOC CLINICAL ONCOLOGY. 2018

View details for DOI 10.1200/JCO.2018.36.15_suppl.e20575

View details for Web of Science ID 000442916006474